List of Excipients in API ciprofloxacin hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ciprofloxacin hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | CILOXAN | ciprofloxacin hydrochloride | 0065-0654 | MINERAL OIL | |
| Alcon Laboratories Inc | CILOXAN | ciprofloxacin hydrochloride | 0065-0654 | PETROLATUM | |
| Alcon Laboratories Inc | CILOXAN | ciprofloxacin hydrochloride | 0065-0656 | ACETIC ACID | |
| Alcon Laboratories Inc | CILOXAN | ciprofloxacin hydrochloride | 0065-0656 | BENZALKONIUM CHLORIDE | |
| Alcon Laboratories Inc | CILOXAN | ciprofloxacin hydrochloride | 0065-0656 | EDETATE DISODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ciprofloxacin hydrochloride
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Henry Schein Inc | ciprofloxacin hydrochloride | 0404-7187 | ACETIC ACID |
| Henry Schein Inc | ciprofloxacin hydrochloride | 0404-7187 | BENZALKONIUM CHLORIDE |
| Henry Schein Inc | ciprofloxacin hydrochloride | 0404-7187 | EDETATE DISODIUM |
| Henry Schein Inc | ciprofloxacin hydrochloride | 0404-7187 | HYDROCHLORIC ACID |
| Henry Schein Inc | ciprofloxacin hydrochloride | 0404-7187 | MANNITOL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for ciprofloxacin hydrochloride
Excipient focus: ACETIC ACID
ciprofloxacin hydrochloride drug variants containing ACETIC ACID
ciprofloxacin hydrochloride drug variants not containing ACETIC ACID
Excipient focus: BENZALKONIUM CHLORIDE
ciprofloxacin hydrochloride drug variants containing BENZALKONIUM CHLORIDE
ciprofloxacin hydrochloride drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: BENZYL ALCOHOL
ciprofloxacin hydrochloride drug variants containing BENZYL ALCOHOL
ciprofloxacin hydrochloride drug variants not containing BENZYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ciprofloxacin hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
ciprofloxacin hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
ciprofloxacin hydrochloride drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | ciprofloxacin hydrochloride | 10544-606 |
| State of Florida DOH Central Pharmacy | ciprofloxacin hydrochloride | 53808-0223 |
| >Company | >Ingredient | >NDC |
ciprofloxacin hydrochloride drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
ciprofloxacin hydrochloride drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | ciprofloxacin hydrochloride | 51672-4085 |
| >Company | >Ingredient | >NDC |
ciprofloxacin hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
ciprofloxacin hydrochloride drug variants containing CROSPOVIDONE
ciprofloxacin hydrochloride drug variants not containing CROSPOVIDONE
Excipient focus: EDETATE DISODIUM
ciprofloxacin hydrochloride drug variants containing EDETATE DISODIUM
ciprofloxacin hydrochloride drug variants not containing EDETATE DISODIUM
Excipient focus: ETHYLCELLULOSES
ciprofloxacin hydrochloride drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Limited | ciprofloxacin hydrochloride | 55111-422 |
| >Company | >Ingredient | >NDC |
ciprofloxacin hydrochloride drug variants not containing ETHYLCELLULOSES
Excipient focus: HYDROCHLORIC ACID
ciprofloxacin hydrochloride drug variants containing HYDROCHLORIC ACID
ciprofloxacin hydrochloride drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYPROMELLOSE
ciprofloxacin hydrochloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | ciprofloxacin hydrochloride | 10544-606 |
| Bayer HealthCare Pharmaceuticals Inc | ciprofloxacin hydrochloride | 50419-758 |
| State of Florida DOH Central Pharmacy | ciprofloxacin hydrochloride | 53808-0223 |
| >Company | >Ingredient | >NDC |
ciprofloxacin hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
ciprofloxacin hydrochloride drug variants containing HYPROMELLOSE 2910
ciprofloxacin hydrochloride drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
ciprofloxacin hydrochloride drug variants containing HYPROMELLOSES
ciprofloxacin hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
ciprofloxacin hydrochloride drug variants containing LACTOSE MONOHYDRATE
ciprofloxacin hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
ciprofloxacin hydrochloride drug variants containing LECITHIN, SOYBEAN
ciprofloxacin hydrochloride drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
ciprofloxacin hydrochloride drug variants containing MAGNESIUM STEARATE
ciprofloxacin hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
ciprofloxacin hydrochloride drug variants containing MANNITOL
ciprofloxacin hydrochloride drug variants not containing MANNITOL
Excipient focus: MINERAL OIL
ciprofloxacin hydrochloride drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | ciprofloxacin hydrochloride | 0065-0654 |
| Novartis Pharmaceuticals Corporation | ciprofloxacin hydrochloride | 0078-0841 |
| >Company | >Ingredient | >NDC |
ciprofloxacin hydrochloride drug variants not containing MINERAL OIL
Excipient focus: MODIFIED CORN STARCH
ciprofloxacin hydrochloride drug variants containing MODIFIED CORN STARCH
ciprofloxacin hydrochloride drug variants not containing MODIFIED CORN STARCH
Excipient focus: PETROLATUM
ciprofloxacin hydrochloride drug variants containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | ciprofloxacin hydrochloride | 0065-0654 |
| Novartis Pharmaceuticals Corporation | ciprofloxacin hydrochloride | 0078-0841 |
| >Company | >Ingredient | >NDC |
ciprofloxacin hydrochloride drug variants not containing PETROLATUM
Excipient focus: POLYDEXTROSE
ciprofloxacin hydrochloride drug variants containing POLYDEXTROSE
ciprofloxacin hydrochloride drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
ciprofloxacin hydrochloride drug variants containing POLYETHYLENE GLYCOL
ciprofloxacin hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
ciprofloxacin hydrochloride drug variants containing POLYETHYLENE GLYCOL 400
ciprofloxacin hydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOLS
ciprofloxacin hydrochloride drug variants containing POLYETHYLENE GLYCOLS
ciprofloxacin hydrochloride drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 20
ciprofloxacin hydrochloride drug variants containing POLYSORBATE 20
ciprofloxacin hydrochloride drug variants not containing POLYSORBATE 20
Excipient focus: POLYVINYL ALCOHOL
ciprofloxacin hydrochloride drug variants containing POLYVINYL ALCOHOL
ciprofloxacin hydrochloride drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
ciprofloxacin hydrochloride drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Depomed Inc | ciprofloxacin hydrochloride | 13913-001 |
| Taro Pharmaceuticals USA Inc | ciprofloxacin hydrochloride | 51672-4085 |
| >Company | >Ingredient | >NDC |
ciprofloxacin hydrochloride drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
ciprofloxacin hydrochloride drug variants containing POVIDONE K30
ciprofloxacin hydrochloride drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
ciprofloxacin hydrochloride drug variants containing SILICON DIOXIDE
ciprofloxacin hydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM ACETATE
ciprofloxacin hydrochloride drug variants containing SODIUM ACETATE
ciprofloxacin hydrochloride drug variants not containing SODIUM ACETATE
Excipient focus: SODIUM CHLORIDE
ciprofloxacin hydrochloride drug variants containing SODIUM CHLORIDE
ciprofloxacin hydrochloride drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
ciprofloxacin hydrochloride drug variants containing SODIUM HYDROXIDE
ciprofloxacin hydrochloride drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
ciprofloxacin hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
ciprofloxacin hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
ciprofloxacin hydrochloride drug variants containing STARCH, CORN
ciprofloxacin hydrochloride drug variants not containing STARCH, CORN
Excipient focus: SUCCINIC ACID
ciprofloxacin hydrochloride drug variants containing SUCCINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Limited | ciprofloxacin hydrochloride | 55111-422 |
| >Company | >Ingredient | >NDC |
ciprofloxacin hydrochloride drug variants not containing SUCCINIC ACID
Excipient focus: TALC
ciprofloxacin hydrochloride drug variants containing TALC
ciprofloxacin hydrochloride drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
ciprofloxacin hydrochloride drug variants containing TITANIUM DIOXIDE
ciprofloxacin hydrochloride drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
ciprofloxacin hydrochloride drug variants containing TRIACETIN
ciprofloxacin hydrochloride drug variants not containing TRIACETIN
Excipient focus: WATER
ciprofloxacin hydrochloride drug variants containing WATER
ciprofloxacin hydrochloride drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
